Dr. Scott Pilla earned his M.D. at Robert Wood Johnson Medical School and completed his residency at Johns Hopkins Bayview Medical Center. He completed the Johns Hopkins General Internal Medicine Fellowship in clinical research in 2018. Dr. Pilla is rated as a Distinguished provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Obesity.

Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Dr. Maruthur has a primary care practice at the Levine Group Internal Medicine Practice at Johns Hopkins Green Spring Station. In addition to seeing patients for one-half day per week, Dr. Maruthur conducts clinical research in diabetes with an emphasis on prevention. She is especially interested in community-based approaches to improving diabetes outcomes and individualized medicine, the tailoring of preventive and treatment strategies based on an individual's biology and preferences. Dr. Maruthur also directs the JHU General Internal Medicine Fellowship. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Maruthur is rated as an Advanced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, Obesity, and Gastric Bypass.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as a Distinguished provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.

Mark Corriere is an Endocrinologist in Towson, Maryland. Dr. Corriere is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Thyroid Nodule, and Hypothyroidism.

Dr. Aniket Sidhaye is an assistant professor of medicine and pediatrics at the Johns Hopkins University School of Medicine. His specific clinical interests are cystic fibrosis related endocrine disorders, type 1 diabetes mellitus particularly emerging adults with diabetes, thyroid disorders, metabolic bone disease, and management of hospitalized persons with diabetes. Dr. Sidhaye earned his M.D. from Northwestern University’s Feinberg School of Medicine. He completed his residency at Northwestern University. He performed a research fellowship in endocrinology and metabolism at Northwestern University and also performed fellowships in endocrinology and metabolism at Johns Hopkins. His research interests include CF related diabetes, bone health of CF patients after lung transplant, and the care of emerging adults with type 1 diabetes. In addition, he is a committed educator serving as an advisor in the medical school, co-director for the endocrine course for pre-clinical medical students, and program director for our endocrine fellowship. Dr. Sidhaye is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Type B Insulin Resistance Syndrome, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Paget's Disease of Bone.

Lisa Simonson is a primary care provider, practicing in Internal Medicine in Lutherville Timonium, Maryland. Dr. Simonson is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Prerenal Azotemia, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Todd T. Brown, MD, PhD is a clinical investigator who focuses on body composition, metabolic, and skeletal abnormalities observed in people with HIV, particularly as related to aging. Through translational investigation, epidemiologic studies, and clinical trials, he has been interested in understanding the pathogenesis of glucose disorders, fat changes, hormonal dysregulation, and osteoporosis in people with HIV, the consequences of these conditions (eg cardiovascular disease, frailty), and their optimal evaluation and management. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Low Blood Sugar, Osteoporosis, Malnutrition, Gastric Bypass, and Gastrostomy.

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as an Advanced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy.

Sherita Golden is an Endocrinologist in Baltimore, Maryland. Dr. Golden is rated as an Advanced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Obesity, and Hormone Replacement Therapy (HRT).

Amir Hamrahian, M.D. is an endocrinologist with specialized experience in the treatment of adrenal and pituitary disorders. Dr. Hamrahian is located in Baltimore, Maryland. He received his medical degree from Hacettepe University in Ankara, Turkey, did his internal medicine residency at the University of North Dakota and completed his endocrinology fellowship at the Case Western Reserve University. Dr. Hamrahian is an Associate Professor of Medicine and has published more than 80 peer-reviewed articles, and has served as a co-author in developing guidelines for adrenal and pituitary disorders. He has presented at national and international conferences and has served as the principal investigator for a number of clinical research studies. Accolades received include Teacher of The Year award and Human Subject Research Annual Professional Excellence award in 2003 and 2011, respectively. Dr. Hamrahian has held roles including the chief of endocrinology in Abu Dhabi. Dr. Hamrahian is a co-director of the Adrenal Center. Dr. Hamrahian is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Cushing's disease, Pituitary Tumor, Cushing's syndrome, Ectopic Cushing's syndrome, and Gamma Knife Radiosurgery.

Dr. Jodi Segal is a professor of medicine at the Johns Hopkins University School of Medicine. She has joint appointments in health policy and management, and epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Segal is internationally recognized as a clinician-investigator in comparative effectiveness research and pharmacoepidemiology. She trains investigators to conduct research to advance Johns Hopkins Medicine as a learning health system. She serves as the associate director of the Center for Health Services and Outcomes Research (CHSOR) and the co-director of the Center for Drug Safety and Effectiveness (CDSE), both in the School of Public Health. Dr. Segal received a B.S. from The Pennsylvania State University. She earned her M.D. from the University of Pittsburgh School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her residency at the University of Chicago and a fellowship in general nternal medicine at Johns Hopkins. She is a member of Phi Beta Kappa and Alpha Omega Alpha. Dr. Segal is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Giant Papillary Conjunctivitis, Type 2 Diabetes (T2D), Vernal Keratoconjunctivitis, and Allergic Conjunctivitis.

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Talia Hitt is an assistant professor of pediatrics in the Division of Pediatric Endocrinology at the Johns Hopkins University School of Medicine. Her clinical practice focuses on all endocrine issues, with a particular focus in pediatric diabetes, insulin resistance and obesity. Dr. Hitt received her undergraduate degree from Colby College, after which she performed research in genetics at the Children’s Hospital of Boston. Dr. Hitt then attended the University of Connecticut School of Medicine, where she obtained a dual M.D./M.P.H. (Master of Public Health) degree. She completed her pediatric residency at the Children’s Hospital of Philadelphia, followed by a fellowship in pediatric endocrinology at the Children’s Hospital of Philadelphia. During her fellowship, Dr. Hitt was awarded a prestigious grant from the Pediatric Endocrine Society to support her research in type 2 diabetes. Dr. Hitt also received a second clinical research master’s degree (Master of Science in Health Policy Research) from the University of Pennsylvania during her fellowship. Dr. Hitt’s research focus is on pediatric type 2 diabetes: its development, progression and innovative therapies. She is studying the relationship between insufficient sleep and type 2 diabetes in adolescents. In 2021, Dr. Hitt was awarded a supplemental award to a 2018 National Institute of Diabetes and Digestive and Kidney Diseases R01 award studying cardiometabolic risk among South Asian adolescents compared with African American and white peers. Dr. Hitt has additionally studied the clinical implementation of new therapeutics in pediatric diabetes care. Dr. Hitt is affiliated with the Pediatric Endocrine Society, the Endocrine Society, and the American Diabetes Association. Dr. Hitt is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Type 1 Diabetes (T1D), Short Stature (Growth Disorders), Type 2 Diabetes (T2D), and Low Blood Sugar.

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy.

Dr. Knight joined the Division of Hospital Medicine in 2000. She serves as Chief Medical Information Officer and chair of the Pharmacy & Therapeutics Committee for Johns Hopkins Bayview Medical Center. For Johns Hopkins Medicine she is co-chair of the Clinical Decision Support, Order Set Review and Epic Inpatient Design committees, and Medical Informatics Director of Clinical Communication. She is a Fellow of the American Medical Informatics Association, and was chair of AMIA’s Clinical Decision Support Working Group from 2023-24. In 2024 she won the Award for Support of Clinical Excellence from the Johns Hopkins Medicine Miller Coulson Academy of Clinical Excellence. Videos 2017 Excellence in Service and Professionalism Award - Amy Knight, M.D., JH Bayview Medical Center Lab Website Amy Knight Lab - Lab Website Research in the Amy Knight Lab focuses on methods by which information technology can improve the quality of health care. We investigate the role computer systems can play in expanding patient-doctor communication, streamlining healthcare tasks for both medical students and practitioners, and establishing a higher standard of care. Our studies have explored the effectiveness of semi-automating daily progress notes for improved documentation, peer assessment of professional performance among hospitalists, ways to enable patient-centered care using information technology and other topics. Dr. Knight is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top area of expertise is Low Blood Sugar.

Shahabuddin Soherwardi is a primary care provider, practicing in Internal Medicine in Lutherville, Maryland. Dr. Soherwardi is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Sepsis, Acute Kidney Failure, Peptic Ulcer, Endoscopy, and Gastrostomy. Dr. Soherwardi is currently accepting new patients.

Yusra Azmi is a primary care provider, practicing in Internal Medicine in Timonium, Maryland. Dr. Azmi is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Edema, Heart Failure, and Hypertension. Dr. Azmi is currently accepting new patients.

Qinglin Gao is a primary care provider, practicing in Internal Medicine in Timonium, Maryland. Dr. Gao is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Pleurisy, Atypical Pneumonia, Hospital-Acquired Pneumonia, Endoscopy, and Gastrostomy.